Choosing the right bioanalytical assay platform(s) to support the PK assessment of protein biotherapeutic programs

Bioanalysis

Volumn 7, Issue 10, 2015, Pages 1197-1199

  Chilewski, Shannon D ^a   Jiang, Hao ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

bioanalytical assay platforms; LC MS; ligand binding assays; PK; protein biotherapeutics

Indexed keywords

BIOLOGICAL PRODUCT; REAGENT; PROTEIN;

ANALYTIC METHOD; AUTOMATION; COLORIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GOOD LABORATORY PRACTICE; IMMUNOASSAY; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICROFLUIDIC ANALYSIS; PHARMACOKINETIC ASSAY; QUALITY CONTROL; RECEPTOR BINDING ASSAY; REVIEW; SENSITIVITY ANALYSIS; TOXICITY TESTING; ANIMAL; DRUG DEVELOPMENT; HUMAN; PROCEDURES;

ANIMALS; CHROMATOGRAPHY, LIQUID; DRUG DISCOVERY; HUMANS; MASS SPECTROMETRY; PROTEINS;

EID: 84930586891     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.15.62     Document Type: Review

References (17)

1. Shih JY, Patel V, Watson A et al. Implementation of a universal analytical method in early-stage development of human antibody therapeutics: application to pharmacokinetic assessment for candidate selection. Bioanalysis 4(19), 2357-2365 (2012).
2. Roman J, Qiu J, Dornadula G, Hamuro L, Bakhtiar R, Verch T. Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis. J. Pharmacol. Toxicol. Methods 63(3), 227-235 (2011).
3. Chilewski SD, Dickerson WM, Mora JR, Saab A, Alderman EM. Evaluation of acoustic membrane microparticle (AMMP) technology for a sensitive ligand binding assay to support pharmacokinetic determinations of a biotherapeutic. AAPS J. 16(6), 1366-1371 (2014).
4. Fischer SK, Joyce A, Spengler M et al. Emerging technologies to increase ligand binding assay sensitivity. AAPS J. 17(1), 93-101 (2015).
5. Yang TY, Uhlinger DJ, Ayers SA, O'hara DM, Joyce AP. Challenges in selectivity, specificity and quantitation range of ligand-binding assays: case studies using a microfluidics platform. Bioanalysis 6(8), 1049-1057 (2014).
6. Crisino RM, Luo L, Geist B, Zoghbi J, Spriggs F. Matrix effect in ligand-binding assay: the importance of evaluating emerging technologies. Bioanalysis 6(8), 1033-1036 (2014).
7. Rhyne PW, Wong OT, Zhang YJ, Weiner RS. Electrochemiluminescence in bioanalysis. Bioanalysis 1(5), 919-935 (2009).
8. Varro R, Chen R, Sepulveda H, Apgar J. Bead-based multianalyte flow immunoassays: the cytometric bead array system. Methods Mol. Biol. 378, 125-152 (2007).
9. Soderstrom CI, Spriggs FP, Song W, Burrell S. Comparison of four distinct detection platforms using multiple ligand binding assay formats. J. Immunol. Methods 371(1-2), 106-113 (2011).
10. Mora J, Given Chunyk A, Dysinger M et al. Next generation ligand binding assays-review of emerging technologies' capabilities to enhance throughput and multiplexing. AAPS J. 16(6), 1175-1184 (2014).
11. Zhang YJ, Olah TV, Zeng J. The integration of ligand binding and LC-MS-based assays into bioanalytical strategies for protein analysis. Bioanalysis 6(13), 1827-1841 (2014).
12. Kuang B, King L, Wang HF. Therapeutic monoclonal antibody concentration monitoring: free or total Bioanalysis 2(6), 1125-1140 (2010).
13. Van Den Broek I, Niessen WM, Van Dongen WD. Bioanalytical LC-MS/MS of protein-based biopharmaceuticals. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 929, 161-179 (2013).
14. Gong C, Zeng J, Akinsanya B et al. Development and validation of an LC-MS/MS assay for the quantitation of a PEGylated anti-CD28 domain antibody in human serum: overcoming interference from antidrug antibodies and soluble target. Bioanalysis 6(18), 2371-2383 (2014).
15. Wang Y, Heilig JS. Differentiation and quantification of endogenous and recombinant-methionyl human leptin in clinical plasma samples by immunocapture/mass spectrometry. J. Pharm. Biomed. Anal. 70, 440-446 (2012).
16. Neubert H, Muirhead D, Kabir M, Grace C, Cleton A, Arends R. Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human beta-nerve growth factor. Anal. Chem. 85(3), 1719-1726 (2013).
17. Jiang H, Zeng J, Titsch C et al. Fully validated LC-MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum. Anal. Chem. 85(20), 9859-9867 (2013).